ovarian-cancer

Documents about ovarian-cancer

• Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer#879117ClinicalTrials.gov
• Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer#180368ClinicalTrials.gov
• Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer#966083ClinicalTrials.gov
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy#842053ClinicalTrials.gov
• Institut Paoli Calmettes Ovarian Cancer Database#901904ClinicalTrials.gov
• Transforming Ovarian Cancer Diagnostic Pathways#836144ClinicalTrials.gov
• Short-course HIPEC in Advanced Epithelial Ovarian Cancer#865554ClinicalTrials.gov
• Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer#889701ClinicalTrials.gov
• Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)#892816ClinicalTrials.gov
• MRI in Staging Ovarian Cancer Using MRI Contrast Agent#897705ClinicalTrials.gov
• Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)#860635ClinicalTrials.gov
• Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer#893627ClinicalTrials.gov
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer#897892ClinicalTrials.gov
• Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer#377415ClinicalTrials.gov
• Weekly Topotecan Therapy in Patients With Ovarian Cancer#807289ClinicalTrials.gov
• Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study#907945ClinicalTrials.gov
• Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer#356484ClinicalTrials.gov
• Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer#865964ClinicalTrials.gov
• Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer#904187ClinicalTrials.gov
• Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer#886271ClinicalTrials.gov
• Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer#905206ClinicalTrials.gov
• Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer#905864ClinicalTrials.gov
• Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer#812864ClinicalTrials.gov
• The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer#847360ClinicalTrials.gov
• Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer#885892ClinicalTrials.gov
• IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery#885014ClinicalTrials.gov
• A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha#829321ClinicalTrials.gov
• Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer#849696ClinicalTrials.gov
• Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer#855145ClinicalTrials.gov
• Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma#806061ClinicalTrials.gov
• Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy#201610ClinicalTrials.gov
• Biological Therapy in Treating Patients With Advanced Cancer#861768ClinicalTrials.gov
• A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer#67877ClinicalTrials.gov
• Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer#160364ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer#184945ClinicalTrials.gov
• Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer#834551ClinicalTrials.gov
• PARPi and Ovarian Cancer Survival#839174ClinicalTrials.gov
• Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer#841901ClinicalTrials.gov
• Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer#879381ClinicalTrials.gov
• Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study#880615ClinicalTrials.gov
• Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm#892938ClinicalTrials.gov
• Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer#898491ClinicalTrials.gov
• A Study of SHR-A1811 in Subjects With Ovarian Cancer#900329ClinicalTrials.gov
• OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)#913979ClinicalTrials.gov
• SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer#917158ClinicalTrials.gov
• Efficacy of Letrozole in Recurrent Ovarian Cancer#917277ClinicalTrials.gov
• Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)#850101ClinicalTrials.gov
• Ovarian Cancer Immunology and Immunotherapy: Editorial Note#269354ODU Digital Commons
• PRO for Fighting FT in Ovarian Cancer#882449ClinicalTrials.gov
• Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer#279563ClinicalTrials.gov